Pasithea Therapeutics Corp. Warrants (KTTAW) EPS by Year
KTTAW
Pasithea Therapeutics Corp. Warrants lost $2.91 per diluted share in fiscal year 2025. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Pasithea Therapeutics Corp. Warrants has filed alongside them.
FY2025 annual
EPS (Diluted)-$2.91
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
KTTAW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More Pasithea Therapeutics Corp. Warrants financials
What was Pasithea Therapeutics Corp. Warrants's diluted earnings per share in fiscal year 2025?
Pasithea Therapeutics Corp. Warrants lost $2.91 per diluted share in fiscal year 2025.
How has Pasithea Therapeutics Corp. Warrants's diluted earnings per share changed over the years?
Across the 5 fiscal years this page covers, Pasithea Therapeutics Corp. Warrants (KTTAW) diluted earnings per share went from -$0.21 in fiscal year 2021 to -$2.91 in fiscal year 2025.
What was Pasithea Therapeutics Corp. Warrants's diluted earnings per share in the most recent quarter?
Pasithea Therapeutics Corp. Warrants (KTTAW) reported -$0.16 in diluted earnings per share in Q2 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Pasithea Therapeutics Corp. Warrants (KTTAW) reported on that line in every period on record.
